Genomic characterization and molecular predictive biomarkers for chemotherapy in a real-world population with metastatic triple-negative breast cancer

被引：0
|
作者：
Olsson, Erik
Lindman, Henrik
Digkas, Evangelos
Thurfjell, Viktoria
Ali, Haidar Mir
Kruger, Ute
Wennstig, Anna-Karin
Sundqvist, Marie
Valachis, Antonis
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-15-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-15-05
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer
    Juan Luis Gomez Marti
    Colin H. Beckwitt
    Amanda M. Clark
    Alan Wells
    British Journal of Cancer, 2021, 125 : 1285 - 1298
  • [32] Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom
    Hanna, Daire
    Merrick, Sophie
    Ghose, Aruni
    Devlin, Michael John
    Yang, Dorothy D.
    Phillips, Edward
    Okines, Alicia
    Chopra, Neha
    Papadimatraki, Elisavet
    Ross, Kirsty
    Macpherson, Iain
    Boh, Zhuang Y.
    Michie, Caroline O.
    Swampillai, Angela
    Gupta, Sunnia
    Robinson, Tim
    Germain, Lewis
    Twelves, Chris
    Atkinson, Charlotte
    Konstantis, Apostolos
    Riddle, Pippa
    Cresti, Nicola
    Naik, Jay D.
    Borley, Annabel
    Guppy, Amy
    Schmid, Peter
    Phillips, Melissa
    BRITISH JOURNAL OF CANCER, 2024, 130 (12) : 1916 - 1920
  • [33] Genomic Profiling in Triple-Negative Breast Cancer
    Liedtke, Cornelia
    Bernemann, Christof
    Kiesel, Ludwig
    Rody, Achim
    BREAST CARE, 2013, 8 (06) : 408 - 413
  • [34] SARELIFE: An Italian, multicentric real-world study of sacituzumab govitecan (SG) in pretreated metastatic triple-negative breast cancer (mTNBC)
    Cona, M. S.
    Ruggieri, L.
    Artale, S. A. A.
    Catania, G.
    D'Auria, G.
    Gallerani, E.
    Villa, F.
    Gambaro, A.
    Chirco, A.
    Giordano, M.
    Pistelli, M.
    Verderame, F.
    Bramati, A.
    Stani, S. C.
    Vici, P.
    Meattini, I.
    Tagliaferri, B.
    Tedesco, B.
    Amato, O.
    La Verde, N. M.
    ANNALS OF ONCOLOGY, 2024, 35 : S381 - S382
  • [35] Genomic and immune characterization of triple-negative breast cancer brain metastases
    Vincent, Benjamin G.
    Sambade, Maria
    Chai, Shengjie
    Siegel, Marni B.
    Cuaboy, Luz
    Hoyle, Alan
    Parker, Joel
    Perou, Charles M.
    Anders, Carey K.
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Dose-dense neoadjuvant chemotherapy in triple-negative breast cancer: Real-world data from a developing country.
    Sharma, Rakesh Kumar
    Gogia, Ajay
    Sagiraju, Hari Krishna Raju
    Deo, S. V. Suryanarayana
    Sharma, Dayanand
    Mathur, Sandeep
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkers
    Davis, S. Lindsey
    Eckhardt, S. Gail
    Tentler, John J.
    Diamond, Jennifer R.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (03) : 88 - 100
  • [38] Emerging Predictive Biomarkers of Response to Platinum Therapy in Triple-Negative Breast Cancer
    Mego M.
    Reuben J.M.
    Current Breast Cancer Reports, 2015, 7 (4) : 224 - 231
  • [39] Atezolizumab for metastatic triple-negative breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (10): : E519 - E519
  • [40] Iniparib in Metastatic Triple-Negative Breast Cancer
    Domagala, Pawel
    Lubinski, Jan
    Domagala, Wenancjusz
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (18): : 1780 - 1780
12345